TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 1 | 3 | 4 | 5 | 48 | 91 | 65 | 36 |
S | %wins | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/1/10 17:49 | 11/15/10 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Chouinard Michel | A6 | O | COO,Biov | S.dm | -3,399 | 25.19 | 33 | -135 | -96 | 5 | D | 253 | 90 | 82 | 18 | 3 | 4 | 4 | 1 | 3 | 4 | 5 | 48 | 91 | 65 |
5/11/10 15:49 | 5/11/10 | BVF | Biovail Corp | A6 | Health | Drug | Pharmaceutical Preparations | Chouinard Michel | A6 | O | CCO,Biov | S.d | -212 | 16.95 | 0 | -13 | -84 | 2 | D | ||||||||||||||
3/12/10 16:30 | 3/11/10 | BVF | Biovail Corp International | A6 | Health | Drug | Pharmaceutical Preparations | Chouinard Michel | A6 | O | COO,Biov | S.d | -337 | 15.46 | 0 | -22 | -90 | 2 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |